We Offer Worldwide Shipping
Login Wishlist

Rosavin

$93

  • Brand : BIOFRON

  • Catalogue Number : BF-R1004

  • Specification : 98%

  • CAS number : 84954-92-7

  • Formula : C20H28O10

  • Molecular Weight : 428.43

  • PUBCHEM ID : 9823887

  • Volume : 20mg

In stock

Quantity
Checkout Bulk Order?

Catalogue Number

BF-R1004

Analysis Method

HPLC,NMR,MS

Specification

98%

Storage

2-8°C

Molecular Weight

428.43

Appearance

Yellow paste

Botanical Source

Rhodiola rosea

Structure Type

Phenylpropanoids

Category

Standards;Natural Pytochemical;API

SMILES

C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC=CC3=CC=CC=C3)O)O)O)O)O)O

Synonyms

(2E)-3-Phenylprop-2-en-1-yl 6-O-α-L-arabinopyranosyl-β-D-glucopyranoside/2-(3-phenylprop-2-enoxy)-6-[[3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]oxane-3,4,5-triol/2-(3-phenylprop-2-enoxy)-6-[(3,4,5-trihydroxy-2-oxanyl)oxymethyl]oxane-3,4,5-triol/(2E)-3-Phenyl-2-propen-1-yl 6-O-α-L-arabinopyranosyl-β-D-glucopyranoside/β-D-Glucopyranoside, (2E)-3-phenyl-2-propenyl 6-O-α-L-arabinopyranosyl-/Rhodiola Rosea extract/N1726/Rosavin/β-D-Glucopyranoside, (2E)-3-phenyl-2-propen-1-yl 6-O-α-L-arabinopyranosyl-

IUPAC Name

(2R,3R,4S,5S,6R)-2-[(E)-3-phenylprop-2-enoxy]-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol

Density

1.5±0.1 g/cm3

Solubility

Methanol

Flash Point

382.6±32.9 °C

Boiling Point

709.1±60.0 °C at 760 mmHg

Melting Point

InChl

InChI=1S/C20H28O10/c21-12-9-28-19(17(25)14(12)22)29-10-13-15(23)16(24)18(26)20(30-13)27-8-4-7-11-5-2-1-3-6-11/h1-7,12-26H,8-10H2/b7-4+/t12-,13+,14-,15+,16-,17+,18+,19-,20-/m0/s1

InChl Key

RINHYCZCUGCZAJ-UHAHJPEESA-N

WGK Germany

RID/ADR

HS Code Reference

2932990000

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:84954-92-7) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

PMID

31026730

Abstract

Idiopathic Pulmonary fibrosis (IPF) is diagnosed as a life-threatening, progressive and incurable lung disease characterized by accumulation of extracellular matrix and myofibroblasts, resulting in the function degradation and structural alterations in normal lung parenchyma. Notably, Pulmonary Fibrosis has been considering as a difficult problem in clinical with high mortality and effective treatment strategies. Rosavin, a benzylPropylene glycoside, is isolated from Rhodiola rosea L., exhibiting nootropic, anti-depressant, anti-cancer, anti-inflammatory and anti-oxidative activities. In this study, we attended to elucidate the pharmacological activity of Rosavin for treatment of pulmonary fibrosis induced by bleomycin in mice. The results indicated that Rosavin could significantly ameliorate the lung index and Pathological structure of mice with Pulmonary fibrosis by bleomycin-induced. Additionally, Rosavin could evidently decreased inflammatory cells infiltration in bronchoalveolar lavage fluid and pro-inflammatory cytokines expression in lung tissue specimens induced by bleomycin. Rosavin could down-regulate the expression of hydroxyproline and malondialdehyde and increased the activities of superoxide dismutase, glutathione peroxidase in lung tissue. The expression of Nrf2 were increased, and the expression of NF-κB p65, TGF-β1 and α-SMA were inhibited. The findings revealed the protective effects and the primary mechanism of rosavin on bleomycin-induced pulmonary fibrosis, which provided a scientific foundation for Rosavin as a promising candidate for Pulmonary fibrosis treatment.

Copyright © 2019. Published by Elsevier Masson SAS.

KEYWORDS

Anti-oxidant; Bleomycin; Inflammatory response; Pulmonary fibrosis; Rosavin

Title

Protective effects of Rosavin on bleomycin-induced pulmonary fibrosis via suppressing fibrotic and inflammatory signaling pathways in mice.

Author

Xin X1, Yao D2, Zhang K3, Han S1, Liu D1, Wang H1, Liu X1, Li G1, Huang J4, Wang J5.

Publish date

2019 Jul

PMID

31094215

Abstract

Aim: A sensitive and selective ultra performance LC-MS/MS (UPLC-MS/MS) method was developed to investigate the pharmacokinetics of rosavin as a potential adaptogenic drug isolated from Rhodiola rosa L. in rat plasma with salidroside as an internal standard. Methodology: Chromatographic separation was performed on a UPLC HSS T3 column (1.8 μm, 100 mm × 2.1 mm) with gradient elution. Multiple reaction monitoring was employed for MS analysis. Rosavin and salidroside were determined with multiple reaction monitoring-ion transitions m/z 427.2 → 293.1 and m/z 299.1 → 119.1, respectively. Conclusion: The validated UPLC-MS/MS method showed a satisfied linear range in 5-5000 ng/ml-1 and was successfully applied for the pharmacokinetic study of rosavin in the rat after intravenous and gavage administration.

KEYWORDS

multiple reaction monitoring; pharmacokinetics; rat plasma; rosavin; ultra performance LC-MS/MS

Title

Pharmacokinetic study of rosavin in rat plasma with ultra performance LC-MS/MS after intravenous and gavage administration.

Author

Zhang M1, Hu Z2, Fang B2, Bao X2, Xiang Z3, Wang H2.

Publish date

2019 May


Description :

Empty ...